Textron Aviation Defense Awarded Five-Year Sustaining Engineering and Program Management Contract for Beechcraft T-6 Texan II Fleet
13.4.2026 17:16:00 CEST | Business Wire | Press Release
Textron Aviation Defense LLC, a Textron Inc. (NYSE: TXT) company, today announced that it has been awarded a five-year U.S. government contract valued at over $150,000,000 to provide Sustaining Engineering and Program Management (SEPM) services for the fleet of U.S. Air Force, Navy and Army T-6A, T-6B and T-6D aircraft.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260409177045/en/
Textron Aviation Defense continues to support sustainment of more than 700 Beechcraft T-6 Texan II aircraft under a renewed five‑year SEPM contract
First awarded in 2021, the action extends systems engineering and program management services for an additional five years, covering sustaining and systems engineering, program management and support for maintenance, repairs, modifications and integrity programs. The modification brings the total cumulative face value of the contract to $510,000,000 ceiling, from $240,000,000 ceiling. Work will be performed in Wichita, Kansas.
“This follow‑on SEPM contract reflects the U.S. Government T-6 Joint Program Office’s continued confidence in our team and our ability to keep the T‑6 Texan II fleet mission‑ready,” said Travis Tyler, president and CEO, Textron Aviation Defense. “Our focus remains on sustaining aircraft availability and supporting our customers as they train the next generation of military pilots.”
About the Beechcraft T-6 Texan II
The Beechcraft T-6 Texan II is the world’s premier military flight trainer. Backed by nearly 100 years of experience delivering more than 255,000 aircraft worldwide, the Texan II’s low acquisition, operating and sustainment costs enable global air forces to fast-track pilot production. With an installed base that more than quadruples its closest competitor, the family of Beechcraft T-6 Texan II aircraft has been the world’s number one integrated training system (ITS) for more than 20 years. The Texan II capitalizes on an active production line with an industry-leading Manufacturing Readiness Level (MRL) rating of 10 as well as a proven supply chain.
About Textron Aviation Defense LLC
Textron Aviation Defense LLC is a subsidiary of Textron Aviation Inc. With a legacy of thousands of proven Beechcraft and Cessna Integrated Training Systems produced and missionized in America’s Heartland since WWII, military customers turn to Textron Aviation Defense when they need airborne solutions for their critical missions. Provider of the world’s foremost military flight trainer, Textron Aviation Defense equips militaries worldwide and leads in low acquisition, sustainment and training costs. The Beechcraft T-6 Texan II and AT-6 Wolverine fleet of more than 1,000 aircraft has logged more than 5 million hours across two NATO military flight schools and 15 countries since 2001. For more information, visit www.defense.txtav.com
About Textron
Textron Inc. is a multi-industry company that leverages its global network of aircraft, defense, industrial and finance businesses to provide customers with innovative solutions and services. Textron is known around the world for its powerful brands such as Bell, Cessna, Beechcraft, Pipistrel, Jacobsen, Kautex, Lycoming, E-Z-GO, and Textron Systems. For more information, visit: www.textron.com.
Certain statements in this press release may project revenues or describe strategies, goals, outlook or other non-historical matters; these forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update them. These statements are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements, including, but not limited to, risks related to U.S. Government contracts as described in our filings with the Securities and Exchange Commission.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260409177045/en/
Contacts
Media Contact:
Doug Scott
+1.316.347.0116
dscott2@txtav.com
txtav.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.txtav.com&e
sheet=54489962&newsitemid=20260409177045&lan=en-US&anchor=txtav.com&index=6&md5=
eace518e7bb908b067e7c20246cf2380
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press Release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press Release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that
2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling18.4.2026 04:08:00 CEST | Press Release
The 2026 NAB Show kicks off Saturday, April 18, with the show floor and exhibits opening on April 19, highlighting the most innovative companies and bringing together the world’s most influential voices across media, entertainment and technology for the industry’s premier global event. As the only platform that convenes broadcasters, media companies, content creators and technology innovators at scale, NAB Show continues its century-long legacy as the catalyst for innovation, growth and deal-making in a rapidly evolving, multi-platform world. From artificial intelligence and the creator economy to sports, streaming and cloud transformation, NAB Show is where the tools, talent and ideas driving the future of storytelling converge. “NAB Show is where the global media ecosystem comes together not just to explore what’s next—but to build it,” said Karen Chupka, executive vice president, National Association of Broadcasters. “This year’s Show reflects the accelerating pace of innovation and
2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling18.4.2026 04:08:00 CEST | Press Release
The 2026 NAB Show kicks off Saturday, April 18, with the show floor and exhibits opening on April 19, highlighting the most innovative companies and bringing together the world’s most influential voices across media, entertainment and technology for the industry’s premier global event. As the only platform that convenes broadcasters, media companies, content creators and technology innovators at scale, NAB Show continues its century-long legacy as the catalyst for innovation, growth and deal-making in a rapidly evolving, multi-platform world. From artificial intelligence and the creator economy to sports, streaming and cloud transformation, NAB Show is where the tools, talent and ideas driving the future of storytelling converge. “NAB Show is where the global media ecosystem comes together not just to explore what’s next—but to build it,” said Karen Chupka, executive vice president, National Association of Broadcasters. “This year’s Show reflects the accelerating pace of innovation and
Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product17.4.2026 23:43:00 CEST | Press Release
The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three variants of the tobacco consumables, commercialized under the HEETS brand. This renewal allows PMI to continue sharing reduced-exposure information with U.S. adults 21+ who use traditional tobacco products, such as combustible cigarettes. The agency concluded that renewing the IQOS and HEETS MRTP authorizations is appropriate to promote public health and is expected to benefit the health of the population as a whole taking into account both users of tobacco products and persons who do not currently use tobacco products. “As the only company to have successfully secured and maintained MRTP authorizations for heated tobacco products in the U.S., we are confident that our science-based alternatives can help adult smokers transition away from combustible cigarettes,” said Stacey Kenned
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom